These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23201400)

  • 1. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.
    Nakamura A; Miyake K; Misawa S; Kuno Y; Horii T; Kondo S; Tabe Y; Ohsaka A
    J Hosp Infect; 2013 Feb; 83(2):153-5. PubMed ID: 23201400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.
    Lodise TP; Miller CD; Graves J; Furuno JP; McGregor JC; Lomaestro B; Graffunder E; McNutt LA
    Antimicrob Agents Chemother; 2007 Feb; 51(2):417-22. PubMed ID: 17158943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
    Aloush V; Navon-Venezia S; Seigman-Igra Y; Cabili S; Carmeli Y
    Antimicrob Agents Chemother; 2006 Jan; 50(1):43-8. PubMed ID: 16377665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.
    Defez C; Fabbro-Peray P; Bouziges N; Gouby A; Mahamat A; Daurès JP; Sotto A
    J Hosp Infect; 2004 Jul; 57(3):209-16. PubMed ID: 15236849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.
    Cholley P; Gbaguidi-Haore H; Bertrand X; Thouverez M; Plésiat P; Hocquet D; Talon D
    J Hosp Infect; 2010 Dec; 76(4):316-9. PubMed ID: 20692070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multidrug-resistant Pseudomonas aeruginosa T].
    Kirikae T
    Nihon Rinsho; 2012 Feb; 70(2):231-5. PubMed ID: 22413523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug-Resistant Pseudomonas aeruginosa Keratitis: Risk Factors, Clinical Characteristics, and Outcomes.
    Vazirani J; Wurity S; Ali MH
    Ophthalmology; 2015 Oct; 122(10):2110-4. PubMed ID: 26189185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa].
    Cao B; Wang H; Zhu YJ; Chen MJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):31-5. PubMed ID: 14989823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients.
    Peña C; Suarez C; Tubau F; Dominguez A; Sora M; Pujol M; Gudiol F; Ariza J
    Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):519-22. PubMed ID: 18949495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa.
    Eagye KJ; Kuti JL; Nicolau DP
    Infect Control Hosp Epidemiol; 2009 Aug; 30(8):746-52. PubMed ID: 19583513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.
    Ray GT; Baxter R; DeLorenze GN
    Clin Infect Dis; 2005 Aug; 41(4):441-9. PubMed ID: 16028150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
    Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
    J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa from patients in a teaching hospital, Riyadh, Saudi Arabia, 2001-2005.
    Babay HA
    Jpn J Infect Dis; 2007 May; 60(2-3):123-5. PubMed ID: 17515646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.